首页> 外国专利> ONDANSETRON EXTENDED RELEASE SOLID DOSAGE FORMS FOR TREATING EITHER NAUSEA, VOMITING OR DIARRHEA SYMPTOMS

ONDANSETRON EXTENDED RELEASE SOLID DOSAGE FORMS FOR TREATING EITHER NAUSEA, VOMITING OR DIARRHEA SYMPTOMS

机译:用于治疗恶心,呕吐或腹泻症状的ONDANSETRON扩展释放固体剂型

摘要

A method of treating a patient comprises orally administering a solid oral dosage form comprising a core comprising a non-ionic polymer matrix, a first amount of ondansetron dispersed within the matrix, and a salt dispersed within the matrix, wherein the first amount of ondansetron ranges from about 9 mg to about 28 mg; a first seal coat surrounding the core, wherein the first seal coat is comprised of a non-ionic polymer matrix; and an immediate release drug layer surrounding the first seal coat and comprising a non-ionic polymer and a second amount of ondansetron dispersed therein, wherein the second amount of ondansetron ranges from about 3 mg to about 8 mg, wherein release of ondansetron from the solid oral dosage form provides exposure to ondansetron for a minimum period of 16 hours so as to result in a reduction in frequency of vomiting, nausea, diarrhea, or a combination thereof.
机译:一种治疗患者的方法,包括口服给予固体口服剂型,该固体口服剂型包括包含非离子聚合物基质的核,分散在该基质中的第一量的恩丹西酮和分散在该基质中的盐,其中该第一量的恩丹西酮范围从约9mg到约28mg;围绕芯部的第一密封涂层,其中第一密封涂层由非离子聚合物基体组成;速释药物层围绕第一密封涂层并且包含非离子聚合物和第二量的恩丹西酮分散在其中,其中第二量的恩丹西酮的范围为约3mg至约8mg,其中恩丹西酮从固体中的释放口服剂型提供的恩丹西酮暴露时间最少为16小时,以减少呕吐,恶心,腹泻或其组合的发生频率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号